One in five Americans experiences heartburn at least once a week, and many dismiss the malady as a mere annoyance, choosing to swallow antacids and get on with their lives.
But what they don’t know can hurt them. Left untreated, the condition can lead to Barrett’s esophagus, which in turn can put patients at risk for esophageal cancer, one of the most deadly forms of cancer.
The reason Barrett’s esophagus matters is that patients with at least 3 centimeters of Barrett’s esophagus lining have a 30- to 125-fold increased risk of esophageal cancer compared to the general population. Although the cancer risk figures initially sound frightening, only 3 to 10 percent of persons with Barrett’s esophagus will develop cancer in their lifetime.
At this year’s national scientific meeting Digestive Diseases Week, Mayo Clinic researchers presented new research on the use of fluorescence in situ hybridization (FISH) tests to determine which patients with heartburn might have something more serious.
“Right now, our best indicator of the seriousness of Barrett’s esophagus is the degree of dysplasia, or precancerous changes, found on a biopsy,” says Kenneth Wang, M.D., gastroenterologist at Mayo Clinic. “However, physicians have to biopsy multiple areas of the esophagus and they still may not detect the pre-cancerous cells. Fluorescence in situ hybridization (FISH) could allow for us to change the way doctor’s diagnose Barrett’s esophagus.”
While traditional cytology analysis relies on identifying abnormally shaped cells, the FISH test detects malignant cells using colored DNA probes for specific abnormal genes visible with a fluorescence microscope. Since cancer cells have an abnormal amount of DNA, by FISH these cells show more of the probes compared to normal cells. The advantage of these techniques is that they can easily applied by any endoscopist and the diagnosis can be made on a single abnormal cell.
Click on the following links to view the abstracts which show the in-depth research by the Mayo Clinic team on using FISH for Barrett’s esophagus: Abstract 1 Abstract 2
Below is a link to an edited youtube video with Dr. Wang .
i was diadnosed with barret’s esophagus in 2006 and was told to take prilosect,nexiem, etc. i take 2 over the counter prilosect daily. i had an endoscopy in 2008 the cells had healed. again i was told to continue taking the meds. another endoscopy is scheduled for 12/2010. my question should i continue to take this medication or could i take pepcid complete?
thank you for your answer.
joann